Pamela Contag, PHD

Dr. Contag is an experienced senior executive who has served as the President and CEO for both public (Xenogen Corp., NASDAQ:XGEN), and private companies. Dr. Contag is currently the President and CEO of BioEclipse Therapeutics, and in this role she was ranked in the top 100 most intriguing entrepreneurs of 2018 by Goldman Sachs and was recognized in the top 10 of the San Francisco Bay Area’s Women-Led most Funded Life Science Companies of 2020. While CEO of Xenogen, the company twice received the R&D 100 award for achievements in Physics and Dr. Contag was named one of the "Top 25 Women in Small Business" by Fortune magazine. She was appointed by the White House to the Founding Board of the Startup America Partnership, and served as a National Director for Springboard Enterprises. She received her M.S. and PhD from the University of Minnesota Medical School in Microbiology and Immunology and completed her Postdoctoral Fellowship at Stanford University School of Medicine.